These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9497982)

  • 1. Warfarin potentiation with bezafibrate.
    Beringer TR
    Postgrad Med J; 1997 Oct; 73(864):657-8. PubMed ID: 9497982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between fenofibrate and warfarin.
    Ascah KJ; Rock GA; Wells PS
    Ann Pharmacother; 1998; 32(7-8):765-8. PubMed ID: 9681093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome associated with bezafibrate.
    Sawamura D; Umeki K
    Acta Derm Venereol; 2000; 80(6):457. PubMed ID: 11243650
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe decrease in serum HDL-cholesterol during combination therapy of bezafibrate and pioglitazone.
    Senba H; Kawano M; Kawakami M
    J Atheroscler Thromb; 2006 Oct; 13(5):263-4. PubMed ID: 17146155
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Takayama T; Tsuji S; Taki J; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Dec; 21(12):988-9. PubMed ID: 8957627
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of warfarin by acetaminophen.
    Brown D
    J Fam Pract; 1998 Jun; 46(6):456-7. PubMed ID: 9638105
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrate-induced increase in blood urea and creatinine.
    Lipscombe J; Bargman JM
    Nephrol Dial Transplant; 2001 Jul; 16(7):1515. PubMed ID: 11427661
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed bezafibrate-induced angio-oedema in a 68-year-old man.
    Frendo M; Theuma R; Fava S
    Br J Clin Pharmacol; 2007 Oct; 64(4):560-1. PubMed ID: 17610533
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between warfarin and mango fruit.
    Monterrey-Rodríguez J
    Ann Pharmacother; 2002 May; 36(5):940-1. PubMed ID: 12014354
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the dental patient on anticoagulant medication.
    Rada RE
    Dent Today; 2006 Aug; 25(8):58-63. PubMed ID: 16925162
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute rhabdomyolysis after bezafibrate re-exposure.
    Terrovitou CT; Milionis HJ; Elisaf MS
    Nephron; 1998; 78(3):336-7. PubMed ID: 9546698
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
    Górriz JL; Sancho A; Alcoy E; García-Ramos JL; Pallardó LM
    Nephrol Dial Transplant; 1995 Dec; 10(12):2371-2. PubMed ID: 8808248
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin: an old drug but still interesting.
    Johnson JA
    Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal function changes in diabetic nephropathy induced by bezafibrate.
    Bruce R; Daniels A; Cundy T
    Nephron; 1996; 73(3):490. PubMed ID: 8832617
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated blood concentrations of cyclosporine and kidney failure after bezafibrate in renal graft recipient.
    Hirai M; Tatuso E; Sakurai M; Ichikawa M; Matsuya F; Saito Y
    Ann Pharmacother; 1996; 30(7-8):883-4. PubMed ID: 8826580
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
    Panuccio V; Enia G; Parlongo S; Cutrupi S; Zoccali C
    Nephron; 1996; 73(4):736. PubMed ID: 8856294
    [No Abstract]   [Full Text] [Related]  

  • 19. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometry of abnormal peroxisomes induced by withdrawal of bezafibrate, a hypolipidemic drug in male rat hepatocytes.
    Kondo K; Makita T
    J Vet Med Sci; 1997 Apr; 59(4):297-9. PubMed ID: 9152941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.